MK-1986-018 - A Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Subjects from Birth to <12 Years of Age with Acute Bacterial

Project: Research project

Project Details

StatusActive
Effective start/end date8/1/188/31/50

Funding

  • Merck Sharp & Dohme Corp
  • Merck Sharp & Dohme Corp